Lupus patients get stem cell hope in expanded access trial
NCT ID NCT04907175
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study offers expanded access to a stem cell treatment called HB-adMSCs for people with systemic lupus erythematosus (SLE). It is designed for adults 18 and older who have their own stem cells stored at Hope Biosciences. The goal is to check if the treatment is safe and helps control lupus symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEM; LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.